NET PROFIT (x1000 SEK)
EMPLOYEES
Empros Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
-10,330
|
-9,177
|
-11,868 |
EBITDA |
-11,687
|
-9,213
|
-11,869 |
Total assets |
147,266
|
76,665
|
57,656 |
Current assets |
33,586
|
7,885
|
5,751 |
Current liabilities |
7,133
|
4,775
|
1,453 |
Equity capital |
140,133
|
71,890
|
56,203 |
- share capital |
180
|
155
|
140 |
Employees (average) |
8
|
7
![]() |
7 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
95.2%
|
93.8%
|
97.5% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-7.0%
|
-12.0%
|
-20.6% |
Current ratio |
470.9%
|
165.1%
|
395.8% |
Return on equity (ROE) |
-7.4%
|
-12.8%
|
-21.1% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
1
|
0
|
1 |
Chg. No. of employees % |
14%
|
0%
|
17% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.